Immune drugs hold hope of "clinical cure" for deadly skin cancer

By Kate Kelland AMSTERDAM (Reuters) - A new generation of drugs designed to trigger the immune system to fight cancer is offering the prospect of a "clinical cure" for some melanoma skin cancer patients who until a few years ago were more likely to be facing a swift death. Cancer specialists gathering for a European conference at the weekend said the so-called immunotherapy drugs, a class led by Bristol-Myers Squibb's Yervoy, or ipilimumab, have transformed an area of oncology in which until recently doctors barely had time to get to know their patients. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/immune-drugs-hold-hope-clinical-cure-deadly-skin-192745851--finance.html